GNMX - Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF
GNMXtargets pure-play or the top 10 companies materially involved ingenomics and precision medicine, including those focused on gene sequencing, molecular diagnostics, gene editing and therapy, targeted treatments, and related healthcare technologies. The fund considers companies deriving significant revenue from this theme, spanningthose thatsupport personalized medicine through bioinformatics, clinical data platforms, laboratory tools, and services that improve disease detection, patient stratification, and treatment development. Using a bottom-up approach that combines fundamental analysis with thematic and quantitative screening, the fund invests in US and international stocks of any market capitalization.
As of Sep 29, 2026: spot at $38.33, ATM IV 37.1%, max pain $37.00, net GEX $7.0K.
- Sector
- Financial Services
- Industry
- Asset Management
- Market Cap
- $2.1M
- Beta
- 2.45
- 52-Week Range
- 23.88-38.7
- IPO Date
- May 6, 2026
- Exchange
- CBOE
What GNMX Looks Like to Options Traders Today
IV rank of 9.0% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($7.0K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.031) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The GNMX overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure.
Frequently asked GNMX overview questions
- What is GNMX?
- GNMX is the ticker symbol for Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF, an listed exchange-traded fund. GNMXtargets pure-play or the top 10 companies materially involved ingenomics and precision medicine, including those focused on gene sequencing, molecular diagnostics, gene editing and therapy, targeted treatments, and related healthcare technologies. The fund considers companies deriving significant revenue from this theme, spanningthose thatsupport personalized medicine through bioinformatics, clinical data platforms, laboratory tools, and services that improve disease detection, patient stratification, and treatment development. Listed on CBOE. GNMX is the ETF ticker shown on this page; ETF traders use the fund for diversified exposure to its underlying basket, for sector and factor rotation, and for hedging or replication strategies via the listed options chain.
- What does the GNMX options snapshot look like today?
- As of Sep 29, 2026, the GNMX options snapshot shows spot at $38.33, ATM IV 37.1%, IV rank 9.0%, max pain $37.00, net GEX $7.0K, expected move 10.64%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are GNMX's key statistics?
- Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF (GNMX) carries a market capitalization of $2.1M, 52-week range of 23.88-38.7. Full holdings disclosure, expense ratio, and tracking-error history live on the per-ticker fundamentals page or the sponsor's site; daily NAV and premium/discount-to-NAV are accessible from the same view. These structural inputs frame how the ETF options market prices implied volatility relative to its constituents.
- What sector or industry does GNMX belong to?
- Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF operates in the Financial Services sector, in the Asset Management industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare GNMX's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the GNMX data on this page?
- The options snapshot above is dated Sep 29, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Fund-level fields (sponsor, expense ratio, holdings concentration where available) refresh from the vendor feed nightly. ETF-specific filings (N-CSR, N-PX, N-CEN) update on the SEC EDGAR cadence. FINRA microstructure data refreshes on the source's cadence; for ETFs the off-exchange volume signal is dominated by authorized-participant creation and redemption rather than directional flow.